Cadre Beats Q3, Raises 2026 Guidance Again and Authorizes $100M Buyback
CDRE sits 28% above its 52-week low of $24.07.
Summary
Cadre beat Q3 estimates with $202.9M of sales and $41.1M of Adjusted EBITDA, raised 2026 guidance for the second straight quarter, and authorized its first $100M share repurchase program.
Key Events · Earnings and Guidance · CDRE
-
Q3 Beat and Guidance Raised Again
Net sales of $202.9M versus guidance of ~$190M and Adjusted EBITDA of $41.1M versus ~$34M. Full-year 2026 net sales guidance lifted to $756M-$769M from $749M-$769M and Adjusted EBITDA to $140M-$144M from $139M-$144M.
-
$100M Inaugural Buyback Authorized
The board authorized repurchases of up to $100M of common stock on November 4, 2026, executable through open-market purchases, block trades or Rule 10b5-1 plans.
-
Margins Expand on Pricing and Mix
Gross margin rose 70 bps to 43.4% and Adjusted EBITDA margin rose 110 bps to 20.2%, with net income up 46% to $16.0M, or $0.37 per diluted share.
-
Leverage Rises With Acquisition Spend
Net debt increased to $305.6M from $184.4M at December 31, 2025 after $164.8M of business acquisitions, putting net debt at 2.2x LTM Adjusted EBITDA of $138.6M.
Analysis · CDRE · Industrial Applications And Services
Cadre delivered a clean beat — $202.9M of sales against ~$190M guidance and $41.1M of Adjusted EBITDA against ~$34M — and raised full-year guidance for the second quarter in a row. The bigger news for the share count is the new $100M repurchase authorization, the company's first, which offsets some of the heavy insider selling seen since August and gives management a tool to support the stock. The offsetting consideration is leverage: net debt climbed to $305.6M from $184.4M at year-end as acquisitions consumed $164.8M of cash, leaving 2.2x net leverage — enough room to keep buying companies and repurchase stock, but not unlimited.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CDRE was trading at $30.84 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $24.07 to $48.76. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.